Photoperiod reverses the effects of estrogens on male aggression via genomic and nongenomic pathways

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 23, 2007, Pages 9840-9845

  Trainor, Brian C ^a,c   Lin, Shili ^b   Finy, M Sima ^a   Rowland, Michael R ^a   Nelson, Randy J ^a  

^a Institute for Behavioral Medicine Research   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Estrogen receptor; Peromyscus polionotus; Seasonality; Social behavior

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FADROZOLE; PROPYL PYRAZOLE TRIOL; PYRAZOLE DERIVATIVE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DAY LENGTH; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; ESTROGEN ACTIVITY; GENE EXPRESSION; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEROMYSCUS; PHOTOPERIODICITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEASONAL VARIATION; SOCIAL BEHAVIOR; STRIA TERMINALIS;

AGGRESSION; ANIMALS; ESTROGENS; GENE EXPRESSION REGULATION; LIGHT; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEROMYSCUS; PHOTOPERIOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPTAL NUCLEI; SIGNAL TRANSDUCTION;

PEROMYSCUS POLIONOTUS;

EID: 34547445154     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701819104     Document Type: Article

References (53)

1. Lesch KP (2004) J Psych Neurosci 29:174-184.
2. Nelson RJ, Chiavegatto S (2001) Trends Neurosci 24:713-719.
3. Trainor BC, Kyomen HH, Marler CA (2006) Front Neuroendocrinol 27:170-179.
4. Vasudevan N, Pfaff DW (2006) Endocr Rev 28:1-19.
5. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen JS, Andersson G, Enmark E, Pettersson K, Warner M, Gustaffson J-A (2001) Physiol Rev 81:1535-1565.
6. Lonard DM, O'Malley BW (2006) Cell 125:411-414.
7. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ESJ, Nethrapalli IS, Tinnikov AA (2002) J Neurosci 22:8391-8401.
8. White R, Lees JA, Needham M, Ham J, Parker M (1987) Mol Endocrinol 1:735-744.
9. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustaffson J-A (1996) Proc Natl Acad Sci USA 93:5925-5930.
10. Beyer C, Pawlak J, Karolczak M (2003) J Neurochem 87:545-550.
11. Abraham IM, Todman MG, Korach KS, Herbison AE (2004) Endocrinology 145:3055-3061.
12. Trainor BC, Martin LBI, Greiwe KM, Kuhlman JR, Nelson RJ (2006) Gen Comp Endocrinol 148:252-259.
13. Jasnow AM, Huhman KL, Bartness TJ, Demas GE (2000) Horm Behav 38:102-110.
14. Caldwell HK, Albers HE (2004) Horm Behav 46:444-449.
15. Ogawa S, Lubahn DB, Korach KS, Pfaff DW (1997) Proc Natl Acad Sci USA 94:1476-1481.
16. Ogawa S, Chan J, Chester AE, Gustafsson J, Korach KS, Pfaff DW (1999) Proc Natl Acad Sci USA 96:12887-12892.
17. Scordalakes EM, Rissman EF (2003) Behav Neurosci 117:38-45.
18. Toufexis DJ, Myers KM, Davis M (2006) Horm Behav 50:539-549.
19. Goodson JL (2005) Horm Behav 48:11-22.
20. Newman S (1999) Ann NY Acad Sci 877:242-257.
21. Trainor BC, Bird IM, Marler CA (2004) Horm Behav 45:115-121.
22. Stauffer S, Coletta C, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen B, Katzenellenbogen J (2000) J Med Chem 43:4934-4947.
23. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) J Med Chem 44:4230-4251.
24. Walf A, Frye C (2005) Neuropsychopharmacology 30:1598-1609.
25. Lund TD, Rovis T, Chung WC, Handa RJ (2005) Endocrinology 146:797-807.
26. Prendergast BJ, Mosinger BJ, Kolattukudy PE, Nelson RJ (2002) Proc Natl Acad Sci USA 99:16291-16296.
27. Renn SCP, Aubin-Horth N, Hofmann HA (2005) BMC Genomics 5:42.
28. Lin C-Y, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, et al. (2006) Genome Biol 5:R66.
29. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP, et al. (2006) Mol Cell 21:393-404.
30. Benjamini Y, Hochberg Y (1995) J R Stat Soc 57:289-300.
31. Trainor BC, Greiwe KM, Nelson RJ (2006) Horm Behav 50:338-345.
32. Nabekura J, Oomura Y, Minami T, Minzuno Y, Fukuda A (1986) Science 233:226-228.
33. Cross E, Roselli CE (1999) Am J Physiol 276:R1346-R1350.
34. Cornil CA, Dalla C, Papadopoulou-Daifoti Z, Ballien M, Balthazart J (2006) Behav Brain Res 166:110-123.
35. Dominguez-Salazar E, Shetty S, Rissman EF (2006) J Neuroendocrinol 18:195-202.
36. Davidson JM (1969) Endocrinology 84:1365-1372.
37. Sodersten P (1973) Horm Behav 4:247-256.
38. Woolley CS (2006) Annu Rev Pharmacol Toxicol 47:657-680.
39. Gu Q, Moss RL (1996) J Neurosci 16:3620-3629.
40. Shingo AS, Kito S (2002) J Neural Transm 109:171-174.
41. Singh M, Setalo GJ, Guan X, Frail DF, Toran-Allerand CD (2000) J Neurosci 20:1694-1700.
42. Wu TW, Wang JM, Chen S, Brinton RD (2005) Neuroscience 135:59-72.
43. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, et al. (2001) Cell 104:719-730.
44. Choleris E, Gustaffson J-A, Korach KS, Muglia LJ, Pfaff DW, Ogawa S (2003) Proc Natl Acad Sci USA 100:6192-6197.
45. Mong JA, Pfaff DW (2004) Mol Psychiatry 9:550-556.
46. Björnström L, Sjöberg M (2005) Mol Endocrinol 19:833-842.
47. McDonnell DP, Norris JD (2002) Science 296:1642-1644.
48. McEwen B (2002) Recent Prog Horm Res 57:357-384.
49. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS (2003) Endocrinology 44:3159-3166.
50. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) Bioinformatics 19:185-193.
51. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Biostatistics 4:249-264.
52. Bajic VB, Tan SL, Chong A, Tang S, Strom A, Gustaffson J-A, Lin C-Y, Liu E (2003) Nucleic Acids Res 31:3605-3607.
53. Trainor BC, Rowland MR, Nelson RJ, Eur J Neurosci, in press.